These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9046013)

  • 1. Selective blockade of N-type voltage-sensitive calcium channels protects against brain injury after transient focal cerebral ischemia in rats.
    Bowersox SS; Singh T; Luther RR
    Brain Res; 1997 Feb; 747(2):343-7. PubMed ID: 9046013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats.
    Campbell CA; Mackay KB; Patel S; King PD; Stretton JL; Hadingham SJ; Hamilton TC
    Exp Neurol; 1997 Nov; 148(1):45-50. PubMed ID: 9398449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of SB-221420-A - a neuronal Ca(2+) and Na(+) channel antagonist in experimental models of stroke.
    Campbell CA; Barone FC; Benham CD; Hadingham SJ; Harries MH; Harling JD; Hills JM; Lewis VA; Mackay KB; Orlek BS; White RF; Parsons AA; Hunter AJ
    Eur J Pharmacol; 2000 Aug; 401(3):419-28. PubMed ID: 10936502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selective N-type Ca(2+)-channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia.
    Buchan AM; Gertler SZ; Li H; Xue D; Huang ZG; Chaundy KE; Barnes K; Lesiuk HJ
    J Cereb Blood Flow Metab; 1994 Nov; 14(6):903-10. PubMed ID: 7929655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-course and treatment response with SNX-111, an N-type calcium channel blocker, in a rodent model of focal cerebral ischemia using diffusion-weighted MRI.
    Yenari MA; Palmer JT; Sun GH; de Crespigny A; Mosely ME; Steinberg GK
    Brain Res; 1996 Nov; 739(1-2):36-45. PubMed ID: 8955922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A selective N-type calcium channel antagonist reduces extracellular glutamate release and infarct volume in focal cerebral ischemia.
    Takizawa S; Matsushima K; Fujita H; Nanri K; Ogawa S; Shinohara Y
    J Cereb Blood Flow Metab; 1995 Jul; 15(4):611-8. PubMed ID: 7790409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNX-111, a novel, presynaptic N-type calcium channel antagonist, is neuroprotective against focal cerebral ischemia in rabbits.
    Perez-Pinzon MA; Yenari MA; Sun GH; Kunis DM; Steinberg GK
    J Neurol Sci; 1997 Dec; 153(1):25-31. PubMed ID: 9455974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P/Q-type Ca2+ channel blocker omega-agatoxin IVA protects against brain injury after focal ischemia in rats.
    Asakura K; Matsuo Y; Kanemasa T; Ninomiya M
    Brain Res; 1997 Nov; 776(1-2):140-5. PubMed ID: 9439806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The omega-conopeptide SNX-111, an N-type calcium channel blocker, dramatically ameliorates brain damage due to transient focal ischaemia.
    Zhao Q; Smith ML; Siesjö BK
    Acta Physiol Scand; 1994 Apr; 150(4):459-61. PubMed ID: 8036915
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of an N-type calcium channel antagonist (SNX 111; Ziconotide) on calcium-45 accumulation following fluid-percussion injury.
    Samii A; Badie H; Fu K; Luther RR; Hovda DA
    J Neurotrauma; 1999 Oct; 16(10):879-92. PubMed ID: 10547097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic localization of N-type VGCCs in gerbil hippocampus and failure of omega-conotoxin MVIIA to attenuate neuronal injury after transient cerebral ischemia.
    Azimi-Zonooz A; Kawa CB; Dowell CD; Olivera BM
    Brain Res; 2001 Jul; 907(1-2):61-70. PubMed ID: 11430886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia.
    Valentino K; Newcomb R; Gadbois T; Singh T; Bowersox S; Bitner S; Justice A; Yamashiro D; Hoffman BB; Ciaranello R
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7894-7. PubMed ID: 8102803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuroprotective effects of intrathecal administration of the selective N-type calcium channel blocker ziconotide in a rat model of spinal ischemia.
    Burns LH; Jin Z; Bowersox SS
    J Vasc Surg; 1999 Aug; 30(2):334-43. PubMed ID: 10436454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre- and post-treatment with MK-801 but not pretreatment alone reduces neocortical damage after focal cerebral ischemia in the rat.
    Dirnagl U; Tanabe J; Pulsinelli W
    Brain Res; 1990 Sep; 527(1):62-8. PubMed ID: 2149295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ifenprodil, a polyamine site NMDA receptor antagonist, on reperfusion injury after transient focal cerebral ischemia.
    Doğan A; Rao AM; Başkaya MK; Rao VL; Rastl J; Donaldson D; Dempsey RJ
    J Neurosurg; 1997 Dec; 87(6):921-6. PubMed ID: 9384405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate.
    Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential blockade of voltage-sensitive calcium channels at the mouse neuromuscular junction by novel omega-conopeptides and omega-agatoxin-IVA.
    Bowersox SS; Miljanich GP; Sugiura Y; Li C; Nadasdi L; Hoffman BB; Ramachandran J; Ko CP
    J Pharmacol Exp Ther; 1995 Apr; 273(1):248-56. PubMed ID: 7714772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of subcutaneous administration of calcium channel blockers on nerve injury-induced hyperalgesia.
    White DM; Cousins MJ
    Brain Res; 1998 Aug; 801(1-2):50-8. PubMed ID: 9729273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebroventricular injection of human prostatic acid phosphatase has potent neuroprotective effects against transient focal cerebral ischemia in rats.
    Yang Y; Bai X; Dong H; Lu Y; Xiong L
    Neurosci Lett; 2011 Oct; 504(3):321-4. PubMed ID: 21982807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the binding of omega-conopeptides to different classes of non-L-type neuronal calcium channels.
    Kristipati R; Nádasdi L; Tarczy-Hornoch K; Lau K; Miljanich GP; Ramachandran J; Bell JR
    Mol Cell Neurosci; 1994 Jun; 5(3):219-28. PubMed ID: 8087420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.